Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicycle Therapeutics Limited

8.07
-0.6900-7.88%
Post-market: 7.84-0.2300-2.85%19:32 EDT
Volume:309.14K
Turnover:2.51M
Market Cap:559.80M
PE:-2.30
High:8.48
Open:8.23
Low:7.95
Close:8.76
52wk High:25.39
52wk Low:6.10
Shares:69.37M
Float Shares:3.08M
Volume Ratio:1.29
T/O Rate:10.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5033
EPS(LYR):-2.9039
ROE:-31.42%
ROA:-19.07%
PB:0.84
PE(LYR):-2.78

Loading ...

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT Newswires Live
·
Oct 16

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
Oct 13

Bicycle Therapeutics Chief Product & Supply Chain Officer Michael Charles Ferguson Reports Disposal of Common Shares

Reuters
·
Oct 07

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading

MT Newswires Live
·
Oct 02

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live
·
Sep 29

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

MT Newswires Live
·
Sep 15

Bicycle Therapeutics plc Files Initial Statement of Beneficial Ownership for Director Herve Hoppenot

Reuters
·
Sep 11

Bicycle Therapeutics Plc - Increases Board Size to Ten Directors - SEC Filing

THOMSON REUTERS
·
Sep 09

BRIEF-Bicycle Therapeutics Strengthens Board Of Directors With New Appointments

Reuters
·
Sep 09

Bicycle Therapeutics Announces New Board Appointments, Welcoming Roger Dansey and Hervé Hoppenot to Strengthen Leadership

Reuters
·
Sep 09

European Equities Traded in the US as American Depositary Receipts Start Week Sharply Lower in Tuesday Trading

MT Newswires Live
·
Sep 02

Bicycle Therapeutics plc Files Initial Statement of Beneficial Ownership for Director Robert Charles Swanton

Reuters
·
Aug 15

Bicycle Therapeutics Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 11

Bicycle Therapeutics Plc : Oppenheimer Cuts Target Price to $44 From $48

THOMSON REUTERS
·
Aug 11

RBC Capital Adjusts Price Target on Bicycle Therapeutics to $27 From $25, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 11

BRIEF-Bicycle Therapeutics PLC Files For Mixed Shelf Offering Of $500 Million- SEC Filing

Reuters
·
Aug 09

Bicycle Therapeutics Files $500 Million Mixed Shelf

MT Newswires Live
·
Aug 09

Bicycle Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Aug 08

Bicycle Therapeutics' Cash And Cash Equivalents Of $721.5M As Of June 30, 2025, With Expected Financial Runway Extended Into 2028

Benzinga
·
Aug 08

Bicycle Therapeutics Q2 EPS $(1.14) Misses $(0.97) Estimate, Sales $2.920M Miss $8.714M Estimate

Benzinga
·
Aug 08